Oral and intraperitoneal treatment of Trypanosoma brucei brucei with a combination of ascofuranone and glycerol in mice

Parasitology International

Volumn 47, Issue 2, 1998, Pages 131-137

  Yabu, Yoshisada ^a   Minagawa, Nobuko ^b   Kita, Kiyoshi ^c   Nagai, Kazuo ^d   Honma, Masakatsu ^b   Sakajo, Shigeru ^b   Koide, Tatsuo ^e   Ohta, Nobuo ^a   Yoshimoto, Akio ^b  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^e NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Ascofuranone; Chemotherapy; Intraperitoneal; Mouse; Oral; Trypanosoma brucei brucei

Indexed keywords

ASCOFURANONE; FURANONE DERIVATIVE; GLYCEROL; UNCLASSIFIED DRUG;

AFRICAN TRYPANOSOMIASIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; DRUG SCREENING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TRYPANOSOMA BRUCEI;

EID: 0032104474     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5769(98)00011-7     Document Type: Article

References (41)

1. [1] Kuzoe, F.A.S. (1993) Current situation of African trypanosomiasis. Acta Trop. 54, 153-162.
2. [2] Wang, C.C. (1995) Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis. Annu. Rev. Pharmacol. Toxicol. 35, 93-127.
3. [3] Bales, J.D., Harrison, S.M., Mbwabi, D.L. and Schechter, P.J. (1989) Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya. Ann. Trop. Med. Parasitol. 83 (Suppl. 1), 111-114.
4. [4] Bacchi, C.J., Nathan, H.C., Livingston, T., Valladares, G., Saric, M., Sayer, P.D., Njogu, A.R. and Clarkson, A.B. (1990) Differential susceptibility to DL-α-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense. Antimicrob. Agents Chemother. 34, 1183-1188.
5. [5] Iten, M., Matovu, E., Brun, R. and Kaminsky, R. (1995) Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-α-difluoromethylornithine (DFMO). Trop. Med. Parasitol. 46, 190-194.
6. [6] Ainanshe, O.A., Jennings, F.W. and Holmes, P.H. (1992) Isolation of drug-resistant strains of Trypanosoma congolense from the lower Shabelle region of Southern Somalia. Trop. Anim. Health Prod. 24, 65-73.
7. [7] Codija, V., Mulatu, W., Majiwa, P.A., Leak, S.G., Lowlands, G.J., Authie, E., d'leteren, G.D. and Peregrine, A.S. (1993) Epidemiology of bovine trypanosomiasis in the Ghibe valley, southwest Ethiopia. 3. Occurrence of populations of Trypanosoma congolense resistant to diminazene, isometamidium and homidium. Acta Trop. 53, 151-163.
8. [8] Minagawa, N., Yabu, Y., Kita, K., Nagai, K., Ohta, N., Meguro, K., Sakajo, S. and Yoshimoto, A. (1996) An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 81, 127-136.
9. [9] Sasaki, H., Hosokawa, T., Sawada, M. and Ando, K. (1973) Isolation and structure of ascofuranone and ascofuranol, antibiotics with hypolipidemic activity. J. Antibiot. 26, 676-680.
10. [10] van der Meer, C., Versluijs-Broers, J.A.M. and Opperdoes, F.R. (1979) Trypanosoma brucei: Trypanocidal effect of salicylhydroxamic acid plus glycerol in infected rats. Exp. Parasitol. 48, 126-134.
11. [11] Zhang, Z.Q., Giroud, C. and Baltz, T. (1991) In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, Melcy, quinapyramine and isometamidium. Acta Trop. 50, 101-110.
12. [12] Kaminsky, R., Schmid, C., Grether, Y., Holy, A., De Clercq, E., Naesens, L. and Brun R. (1996) (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine [(S)-HPMPA]: a purine analogue with trypanocidal activity in vitro and in vivo. Trop. Med. Int. Health 1, 255-263.
13. [13] Magae, J., Hosokawa, T., Ando, K., Nagai, K. and Tamura, G. (1982) Antitumor protective property of an isoprenoid antibiotic, ascofuranone. J. Antibiot. 35, 1547-1552.
14. [14] Magae, J., Nagai, K., Ando, K., Yamasaki, M. and Tamura, G. (1983) Effects of an antitumor agent, ascofuranone, on the macromolecular syntheses of intact cells. J. Antibiot. 36, 892-899.
15. [15] Magae, J., Hotta, M., Nagai, K., Suzuki, S. Ando, K., Yamasaki, M. and Tamura, G. (1986) Activation of natural cytotoxic activity and concomitant reduction of triglyceride content of murine spleen, treated with an antitumor antibiotic, ascofuranone. J. Antibiot. 39, 676-681.
16. [16] Magae, J., Nagai, K., Suzuki, S., Yamasaki, M., Ando, K. and Tamura, G. (1987) Macrophage-specific effect on lipid metabolism by an antibiotic, ascofuranone. J. Antibiot. 40, 202-208.
17. [17] Magae, J., Hayasaki, J., Matsuda, Y., Hotta, M., Hosokawa, T., Suzuki, S., Nagai, K., Ando, K. and Tamura, G. (1988) Antitumor and antimetastatic activity of an antibiotic, ascofuranone, and activation of phagocytes. J. Antibiot. 41, 959-965.
18. [18] Magae, J., Nagai, K., Ando, K. and Tamura, G. (1988) Differentiation of mouse and human myeloid leukemia cells induced by an antitumor antibiotic, ascofuranone. Agric. Biol. Chem. 52, 3143-3147.
19. [19] Minagawa, N., Meguro, K., Sakajo, S. and Yoshimoto A. (1994) Effects of ascofuranone on the mitochondria isolated from Hansenula anomala. Biosci. Biotech. Biochem. 58, 1334-1335.
20. [20] Opperdoes, F.R. (1987) Compartmentation of carbohydrate metabolism in trypanosomes. Ann. Rev. Microbiol. 41, 127-151.
21. [21] Clarkson, A.B., Jr., Bienen, E.J., Pollakis, G. and Grady, R.W. (1989) Respiration of bloodstream forms of the parasite Trypanosoma brucei brucei is dependent on a plant-like alternative oxidase. J. Biol. Chem. 264, 17770-17776.
22. [22] Bienen, E.J., Saric, M., Pollakis, G., Grady, R.W. and Clarkson, A.B., Jr. (1991) Mitochondrial development in Trypanosoma brucei brucei transitional bloodstream forms. Mol. Biochem. Parasitol. 45, 185-192.
23. [23] Hannaert, V. and Michels, P.A.M. (1994) Structure, function, and biogenesis of glycosomes in kinetoplastida. J. Bioenerg. Biomembr. 26, 205-212.
24. [24] Priest, J.W. and Hajduk, S.L. (1994) Developmental regulation of mitochondrial biogenesis in Trypanosoma brucei. J. Bioenerg. Biomembr. 26, 179-191.
25. [25] Kornblatt, J.A., Nthale, J. and McOdimba, F. (1992) Purification of sn-glycerol-3-phosphate dehydrogenase from Trypanosoma brucei brucei. Biochem. Cell Biol. 70, 136-141.
26. [26] Chaudhuri, M., Ajayi, W., Temple, S. and Hill, G.C. (1995) Identification and partial purification of a stage-specific 33 kDa mitochondrial protein as the alternative oxidase of the Trypanosoma brucei brucei bloodstream trypomastigotes. J. Eukaryot. Microbiol. 42, 467-472.
27. [27] Chaudhuri, M. and Hill, G.C. (1996) Cloning, sequencing, and functional activity of the Trypanosoma brucei brucei alternative oxidase. Mol. Biochem. Parasitol. 83, 125-129.
28. [28] Clarkson, A.B., Jr., Grady, R.W., Grossman, S.A., McCallum, R.J. and Brohn, F.H. (1981) Trypanosoma brucei brucei: a systematic screening for alternatives to the salicylhydroxamic acid-glycerol combination. Mol. Biochem. Parasitol. 3, 271-291.
29. [29] Clarkson, A.B., Jr., Bienen, E.J., Pollakis, G. and Grady, R.W. (1989) Trypanocidal CoQ analogs: their effect on other mitochondrial systems. Comp. Biochem. Physiol. 94B, 245-251.
30. [30] Grady, R.W., Bienen, E.J. and Clarkson, A.B., Jr. (1986) p-Alkyloxybenzhydroxamic acids, effective inhibitors of the trypanosome glycerol-3-phosphate oxidase. Mol. Biochem. Parasitol. 19, 231-240.
31. [31] Grady, R.W., Bienen, E.J. and Clarkson, A.B., Jr. (1986) Esters of 3,4-dihydroxybenzoic acid, highly effective inhibitors of the sn-glycerol-3-phosphate oxidase of Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 21, 55-63.
32. [32] Grady, R.W., Bienen, E.J., Dieck, H.A., Saric, M. and Clarkson, A.B., Jr. (1993) N-n-Alkyl-3, 4-dihydroxybenzamides as inhibitors of the trypanosome alternative oxidase: activity in vitro and in vivo. Antimicrob. Agents Chemother. 37, 1082-1085.
33. [33] van der Meer, C., Versluys-Broers, J.A.M. and van Duin, C. Th., van den Ingh, T.S.G.A.M., Nieuwenhuijs, J. and Zwart, D. (1980) Pitfalls of salicylhydroxamic acid plus glycerol treatment of T. vivax infected goats. Trop. Med. Parasitol. 31, 275-282.
34. [34] Brohn, F.H. and Clarkson, A.B., Jr. (1978) Quantitative effects of salicylhydroxamic acid and glycerol on Trypanosoma brucei glycolysis in vitro and in vivo. Acta Trop. 35, 23-33.
35. [35] Evans, D.A., Brightman, C.J. and Holland, M.F. (1977) Salicylhydroxamic acid glycerol in experimental trypanosomiasis. Lancet 2, 769.
36. [36] Clarkson, A.B. Jr. and Brohn F.H. (1976) Trypanosomiasis: an approach to chemotherapy by the inhibition of carbohydrate catabolism. Science 194, 204-206.
37. [37] Fairlamb, A.H., Opperdoes, F.R. and Borst P. (1977) New approach to screening drugs for activity against African trypanosomes. Nature 265, 270-271.
38. [38] Henry, M.F., Bonner W.D. and Nyns, E.J. (1977) Involvement of iron in the biogenesis of the cyanide-insensitive respiration in the yeast Saccharomycopsis lipolytica. Biochim. Biophys. Acta 460, 94-100.
39. [39] Salzmann, U., Ludwig, P., Schewe, T. and Rapoport, S. M. (1985) The share of lipoxygenase in the antimycin-resistant oxygen uptake of intact rabbit reticulocytes. Biomed. Biochim. Acta 44, 213-221.
40. [40] Slapke, J., Becher, G., Schewe, T., Kuhn, H., Forster, W. and Winkler, J. (1987) A test hierarchy for antibronchoconstrictory lipoxygenase inhibitors: in vitro and in vivo experimental tests. Allergol. Immunopathol. 15, 137-141.
41. [41] Macri, F., Braidot, E., Petrussa, E. and Vianello, A. (1994) Lipoxygenase activity associated to isolated soybean plasma membranes. Biochim. Biophys. Acta 1215, 109-114.